AbbVie Inc.
AbbVie Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 9,391 | 5,229 | 5,629 | 6,467 | 5,175 | 5,524 | 7,257 | 13,130 | 18,067 | 12,814 | 13,287 | 8,759 | |||||
Short Term Investments | - | 28 | 42 | 0 | 1 | 31 | 28 | 27 | 2 | 2 | 3 | 7 | |||||
Accounts Receivable Net Current | 12,479 | 12,589 | 12,769 | 12,637 | 12,477 | 10,919 | 11,472 | 11,724 | 11,949 | 11,155 | 11,412 | 11,491 | |||||
Inventory Net | 5,049 | 4,951 | 4,938 | 4,960 | 4,526 | 4,181 | 4,450 | 4,218 | 4,245 | 4,099 | 3,981 | 4,055 | |||||
Prepaid Expense And Other Assets | 6,610 | 6,265 | 5,161 | 5,197 | 5,496 | 4,927 | 4,578 | 4,717 | 4,608 | 4,932 | 4,541 | 4,540 | |||||
Assets Current | 33,529 | 29,062 | 28,539 | 29,261 | 27,675 | 25,582 | 27,785 | 33,816 | 38,871 | 33,002 | 33,224 | 28,852 | |||||
Long Term Investments | 268 | 268 | 291 | 310 | 287 | 279 | 267 | 272 | 305 | 304 | 275 | 288 | |||||
Property Plant And Equipment Net | 5,687 | 5,628 | 5,483 | 5,283 | 5,237 | 5,134 | 5,141 | 5,023 | 4,980 | 4,989 | 4,934 | 4,943 | |||||
Intangible Assets Net Excluding Goodwill | 50,873 | 52,641 | 54,315 | 57,031 | 58,489 | 60,068 | 66,646 | 60,243 | 62,225 | 55,610 | 58,603 | 62,862 | |||||
Goodwill | 35,570 | 35,640 | 35,626 | 35,638 | 35,285 | 34,956 | 35,295 | 33,386 | 33,426 | 32,293 | 32,091 | 32,224 | |||||
Other Assets Noncurrent | 10,536 | 10,721 | 9,644 | 9,659 | 9,192 | 9,142 | 8,288 | 9,197 | 9,067 | 8,513 | 7,094 | 6,198 | |||||
Assets | 136,463 | 133,960 | 133,898 | 137,182 | 136,165 | 135,161 | 143,422 | 141,937 | 148,874 | 134,711 | 136,221 | 135,367 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Short Term Borrowings | 0 | 2,499 | 3,790 | 5,556 | 1,593 | 0 | - | - | 3 | 0 | 2 | 0 | |||||
Long Term Debt And Capital Lease Obligations Curre… | 8,326 | 6,056 | 1,982 | 1,966 | 3,769 | 6,804 | 12,570 | 12,586 | 10,193 | 7,191 | 5,113 | 5,203 | |||||
Accounts Payable And Accrued Liabilities Current | 33,774 | 34,734 | 33,619 | 32,245 | 31,041 | 31,945 | 30,492 | 29,329 | 31,326 | 30,650 | 29,658 | 27,036 | |||||
Liabilities Current | 42,100 | 43,289 | 39,391 | 39,767 | 36,403 | 38,749 | 43,062 | 41,915 | 41,522 | 37,841 | 34,773 | 32,239 | |||||
Long Term Debt And Capital Lease Obligations | 64,532 | 58,941 | 62,971 | 62,959 | 64,527 | 60,340 | 58,509 | 58,048 | 63,805 | 52,194 | 55,631 | 55,812 | |||||
Deferred Income Tax Liabilities Net | 2,332 | 2,389 | 2,480 | 2,554 | 2,582 | 2,579 | 2,749 | 2,726 | 2,722 | 1,952 | 2,044 | 2,124 | |||||
Other Liabilities Noncurrent | 34,111 | 32,569 | 31,655 | 32,040 | 31,191 | 30,129 | 33,031 | 32,427 | 32,778 | 32,327 | 31,644 | 32,294 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value Outstanding | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | |||||
Treasury Stock Value | -10,611 | -9,146 | -9,143 | -9,147 | -9,137 | -8,201 | -7,848 | -7,838 | -7,829 | -6,533 | -6,525 | -6,528 | |||||
Additional Paid In Capital Common Stock | 22,962 | 22,495 | 22,291 | 21,987 | 21,808 | 21,333 | 21,160 | 20,879 | 20,656 | 20,180 | 20,021 | 19,839 | |||||
Retained Earnings Accumulated Deficit | -17,872 | -15,493 | -14,234 | -11,503 | -9,527 | -7,900 | -4,964 | -3,768 | -2,384 | -1,000 | 933 | 1,789 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -1,153 | -1,144 | -1,574 | -1,538 | -1,742 | -1,925 | -2,334 | -2,513 | -2,454 | -2,305 | -2,353 | -2,252 | |||||
Stockholders Equity | -6,612 | -3,228 | -2,599 | -138 | 1,420 | 3,364 | 6,071 | 6,821 | 8,047 | 10,397 | 12,129 | 12,898 | |||||
Minority Interest | 44 | 42 | 43 | 45 | 42 | 39 | 39 | 43 | 40 | 37 | 35 | 32 | |||||
Liabilities And Stockholders Equity | 136,463 | 133,960 | 133,898 | 137,182 | 136,165 | 135,161 | 143,422 | 141,937 | 148,874 | 134,711 | 136,221 | 135,367 | |||||
Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Common Stock Shares Authorized | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | |||||
Common Stock Shares Issued | 1,844 | 1,839 | 1,838 | 1,837 | 1,837 | 1,832 | 1,831 | 1,830 | 1,830 | 1,823 | 1,823 | 1,822 | |||||
Treasury Stock Common Shares | 77 | 71 | 71 | 71 | 71 | 66 | 64 | 64 | 64 | 57 | 57 | 57 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 8.02% | 25.70% | 29.60% | - | - | - | - | - | - | - | - | - |
| 2025 | 0.82% | -1.24% | 3.97% | 6.70% | 11.88% | 16.45% | 5.47% | 6.53% | 2.38% | -2.28% | -7.50% | -9.60% |
| 2024 | -4.11% | 4.03% | 6.17% | 4.69% | 3.88% | 0.98% | -8.75% | -11.20% | -14.25% | 11.11% | -3.06% | 3.85% |
| 2023 | - | - | - | -1.42% | -0.84% | -6.66% | 1.57% | 9.75% | 17.54% | 1.21% | -6.80% | -7.68% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 50+ calculated metrics
Subscribe to unlock 17+ years of data and 50+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 0.80 | 0.67 | 0.72 | 0.74 | 0.76 | 0.66 | 0.65 | 0.81 | 0.94 | 0.87 | 0.96 | 0.89 | |||||
| Quick Ratio | 0.68 | 0.56 | 0.60 | 0.61 | 0.64 | 0.55 | 0.54 | 0.71 | 0.83 | 0.76 | 0.84 | 0.77 | |||||
| Working Capital | -8.57B | -14.23B | -10.85B | -10.51B | -8.73B | -13.17B | -15.28B | -8.10B | -2.65B | -4.84B | -1.55B | -3.39B | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | -6.37 | -13.41 | -15.16 | -288.17 | 25.64 | 11.52 | 7.09 | 6.14 | 5.16 | 3.64 | 2.87 | 2.50 | |||||
| Interest Coverage TTM | 5.80 | 5.74 | 3.50 | 4.38 | 4.32 | 4.23 | 7.17 | 7.07 | 7.60 | 7.58 | 8.45 | 9.24 | |||||
| Debt Ratio | 0.31 | 0.32 | 0.29 | 0.29 | 0.27 | 0.29 | 0.30 | 0.30 | 0.28 | 0.28 | 0.26 | 0.24 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.46 | 0.45 | 0.43 | 0.42 | 0.40 | 0.42 | 0.40 | 0.40 | 0.38 | 0.40 | 0.40 | 0.40 | |||||
| Days Sales Outstanding TTM | 72.50 | 70.15 | 74.17 | 76.22 | 77.71 | 71.51 | 75.20 | 77.03 | 78.57 | 75.29 | 73.33 | 74.04 | |||||
| Receivables Turnover TTM | 5.03 | 5.20 | 4.92 | 4.79 | 4.70 | 5.10 | 4.85 | 4.74 | 4.65 | 4.85 | 4.98 | 4.93 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | 2.05 | 2.38 | 1.36 | 2.13 | 2.37 | 2.42 | 2.90 | 3.02 | 3.39 | 2.75 | 3.68 | 4.91 | |||||
| Free Cash Flow Per Share TTM | 11.29 | 10.07 | 11.13 | 10.32 | 8.70 | 10.08 | 8.83 | 10.06 | 12.37 | 12.48 | 13.99 | 14.03 | |||||
| Dividend Per Share TTM | 6.68 | 6.59 | 6.50 | 6.41 | 6.32 | 6.23 | 6.16 | 6.09 | 6.02 | 5.96 | 5.90 | 5.83 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 70.68% | 70.24% | 69.74% | 70.93% | 70.69% | 69.99% | 67.21% | 62.75% | 62.28% | 62.42% | 65.76% | 68.91% | |||||
| Operating Profit Margin TTM | 24.41% | 24.65% | 15.16% | 18.80% | 17.56% | 16.22% | 24.89% | 22.31% | 23.50% | 23.49% | 27.32% | 31.03% | |||||
| Net Profit Margin TTM | 5.78% | 6.91% | 4.03% | 6.48% | 7.33% | 7.61% | 9.24% | 9.73% | 11.03% | 8.97% | 11.82% | 15.52% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 9.50% | 8.57% | 7.40% | 6.05% | 5.45% | 3.71% | 0.72% | -1.83% | -4.12% | -6.44% | -4.64% | -2.31% | |||||
| Net Income Growth (1Y) | -13.65% | -1.40% | -53.20% | -29.39% | -29.94% | -12.05% | -21.29% | -38.47% | -20.95% | -58.86% | -51.37% | -31.19% | |||||
| EPS Growth (1Y) | -13.74% | -1.40% | -53.20% | -29.39% | -29.90% | -12.10% | -21.38% | -38.51% | -20.91% | -58.79% | -51.26% | -31.07% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | 104.38 | 93.44 | 165.39 | 83.55 | 83.92 | 69.23 | 63.74 | 52.60 | 49.33 | 51.20 | 36.42 | 24.42 | |||||
| P/B TTM | -57.33 | -122.32 | -152.85 | -2,286.78 | 248.55 | 88.20 | 53.88 | 41.25 | 36.80 | 24.00 | 19.58 | 16.46 | |||||
| P/S TTM | 6.03 | 6.46 | 6.66 | 5.41 | 6.15 | 5.27 | 5.89 | 5.12 | 5.44 | 4.59 | 4.31 | 3.79 | |||||
| Market Cap | 379.09B | 394.86B | 397.27B | 315.58B | 352.95B | 296.72B | 327.13B | 281.38B | 296.14B | 249.50B | 237.47B | 212.29B | |||||
| Enterprise Value | 442.56B | 457.13B | 460.38B | 379.59B | 417.66B | 358.34B | 390.95B | 338.89B | 352.08B | 296.07B | 284.93B | 264.54B | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 19.98B | 17.82B | 19.68B | 18.24B | 15.39B | 17.83B | 15.62B | 17.78B | 21.89B | 22.06B | 24.73B | 24.80B | |||||
| Net Debt | 63.47B | 62.27B | 63.11B | 64.01B | 64.71B | 61.62B | 63.82B | 57.50B | 55.93B | 46.57B | 47.46B | 52.26B | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
AbbVie Inc. (ABBV) — SEC Financial Statements & Analysis
AbbVie Inc. (ABBV) is a pharmaceutical preparations company, incorporated in DE. AbbVie Inc. trades on ABBV: NYSE as: ABBV. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), AbbVie Inc. reported a 9.50% year-over-year revenue growth, a Gross Profit Margin of 70.68% (TTM), a Debt-to-Equity ratio of -6.37x, a Price-to-Sales (P/S) ratio of 6.03x (TTM), a Price-to-Book (P/B) ratio of -57.33 (TTM), at a market cap of $379.09B. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 9.50%
- Gross Profit Margin TTM
- 70.68%
- Debt To Equity
- -6.37x
- P/S TTM
- 6.03x
- P/B TTM
- -57.33
- Market Cap
- $379.09B
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is AbbVie Inc. in?
AbbVie Inc. (ABBV) operates in the Pharmaceutical Preparations industry.
What is ABBV's market cap?
AbbVie Inc. (ABBV) has a market capitalization of $379.09B as of 2026-03-31.
What is ABBV's P/E ratio?
AbbVie Inc. (ABBV)'s trailing twelve month P/E ratio is 104.38x as of 2026-03-31.
What exchange does ABBV trade on?
AbbVie Inc. (ABBV) trades on the ABBV: NYSE.
Where is AbbVie Inc. incorporated?
AbbVie Inc. is incorporated in DE.